Molecular pathogenesis of ovarian clear cell carcinoma

被引：31

作者：

Gounaris, Ioannis ^{[1
]}

Brenton, James D. ^{[1
]}

机构：

[1] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 09期

关键词：

ARID1A; endometriosis; genetically engineered mouse models; glycogen; HNF1B; ovarian clear; PIK3CA cell cancer; IDENTIFIES FREQUENT MUTATION; ARID1A PROTEIN EXPRESSION; SWI/SNF-RELATED COMPLEXES; HYPOXIA-INDUCIBLE FACTOR; REMODELING GENE ARID1A; ENDOMETRIAL CANCER; THERAPEUTIC TARGET; GLYCOGEN-SYNTHESIS; TUMOR-SUPPRESSOR; PTEN EXPRESSION;

D O I：

10.2217/fon.15.45

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian clear cell carcinoma is a distinct subtype of epithelial ovarian cancer, characterized by an association with endometriosis, glycogen accumulation and resistance to chemotherapy. Key driver events, including ARID1A mutations and HNF1B overexpression, have been recently identified and their functional characterization is ongoing. Additionally, the role of glycogen in promoting the malignant phenotype is coming under scrutiny. Appreciation of the notion that ovarian clear cell carcinoma is essentially an ectopic uterine cancer will hopefully lead to improved animal models of the disease, in turn paving the way for effective treatments.

引用

页码：1389 / 1405

页数：17

共 50 条

[41] Coexisting clear cell adenocarcinoma and squamous cell carcinoma arising from ovarian endometriosis
Jobo T.
Kawaguchi M.
Imai M.
Migishima F.
Watanabe J.
Kuramoto H.
International Journal of Clinical Oncology, 2000, 5 (6) : 405 - 409
[42] Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
Tan, David S. P.
Iravani, Marjan
McCluggage, W. Glenn
Lambros, Maryou B. K.
Milanezi, Fernanda
Mackay, Alan
Gourley, Charles
Geyer, Felipe C.
Vatcheva, Radost
Millar, Joanne
Thomas, Karen
Natrajan, Rachael
Savage, Kay
Fenwick, Kerry
Williams, Alistair
Jameson, Charles
El-Bahrawy, Mona
Gore, Martin E.
Gabra, Hani
Kaye, Stanley B.
Ashworth, Alan
Reis-Filho, Jorge S.
CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1521 - 1534
[43] Molecular events in the pathogenesis of vulvar squamous cell carcinoma
Xing, Deyin
Fadare, Oluwole
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2021, 38 (01) : 50 - 61
[44] ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
Caumanns, Joseph J.
Wisman, G. Bea A.
Berns, Katrien
van der Zee, Ate G. J.
de Jong, Steven
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 176 - 184
[45] Ovarian clear cell carcinoma associated with endometriosis: a case report with immunohistochemical study
Murta, E. F. C.
Nomelini, R. S.
Ferreira, Ea.
Lima, M. A.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (05) : 403 - 405
[46] Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing
Kim, Se Ik
Lee, Ji Won
Lee, Maria
Kim, Hee Seung
Chung, Hyun Hoon
Kim, Jae-Weon
Park, Noh Hyun
Song, Yong-Sang
Seo, Jeong-Sun
GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 375 - 382
[47] Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
Tong, An
Di, Xiangjie
Zhao, Xia
Liang, Xiao
FRONTIERS IN GENETICS, 2023, 14
[48] The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma
Ju, U. Chul
Kang, Woo Dae
Kim, Seok Mo
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (02) : 177 - 183
[49] Expression of CD10 and cytokeratins in ovarian and renal clear cell carcinoma
Ohta, Y
Suzuki, T
Shiokawa, A
Mitsuya, T
Ota, H
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (03) : 239 - 245
[50] A case of diaphragmatic clear cell carcinoma in a patient with a medical history of ovarian endometriosis
Fujiu, Koichi
Miyamoto, Hideaki
Hashimoto, Satoshi
Suzuki, Nobuyasu
Takano, Yoshinao
Teranishi, Yasushi
Sakuma, Hideo
Suzuki, Hiroyuki
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (05) : 489 - 492

← 1 2 3 4 5 →